A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)
- Resource Type
- Journal Article
- Source
Cancer Chemotherapy & Pharmacology . Nov2013, Vol. 72 Issue 5, p1103-1110. 8p.- Subject
- Language
- ISSN
- 0344-5704